These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9417448)

  • 21. Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease).
    Peery WH
    Am J Med; 1987 May; 82(5):989-97. PubMed ID: 3555068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osler-Weber-Rendu disease: a six generation family.
    Cheng LH; Tsai WJ
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Sep; 8(9):495-502. PubMed ID: 1294765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
    Hanks JE; Hunter D; Goding GS; Boyer HC
    Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intractable epistaxis in Osler-Rendu-Weber syndrome].
    Zalagh M; Errami N; Bouaity B; Hemmaoui B; Itoua W; Benariba F
    Rev Stomatol Chir Maxillofac; 2011 Nov; 112(5):310-2. PubMed ID: 21940027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic embolization for control of epistaxis in a patient with hereditary hemorrhagic telangiectasia.
    Weissman JL; Jungreis CA; Johnson JT
    Am J Otolaryngol; 1995; 16(2):138-40. PubMed ID: 7793510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nasal closure as definitive treatment for epistaxis in Rendu-Osler-Weber disease].
    Alonso-Treceño JL; Alonso-Castañeira I; Escapa-Garrachón JM; Moralejo-Martín J; Enterría-González A; Freijanes-Otero J
    Acta Otorrinolaringol Esp; 2008 Oct; 59(8):420-3. PubMed ID: 18928679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidelines of the French Society of Otorhinolaryngology (SFORL) (short version). Specific treatment of epistaxis in Rendu-Osler-Weber disease.
    Robard L; Michel J; Prulière Escabasse V; Bequignon E; Vérillaud B; Malard O; Crampette L;
    Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Feb; 134(1):37-41. PubMed ID: 27986467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire.
    Karapantzos I; Tsimpiris N; Goulis DG; Van Hoecke H; Van Cauwenberge P; Danielides V
    Eur Arch Otorhinolaryngol; 2005 Oct; 262(10):830-3. PubMed ID: 15739086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epistaxis in patients with hereditary hemorrhagic teleangiectasia].
    Jovancević L; Mitrović SM
    Med Pregl; 2006; 59(9-10):443-9. PubMed ID: 17345820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of haemorrhagic telangiectasia with the flashlamp-pulsed dye laser.
    Ducic Y; Brownrigg P; Laughlin S
    J Otolaryngol; 1995 Oct; 24(5):299-302. PubMed ID: 8537990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease) Management of epistaxis and oral hemorrhage by Nd-Yag laser].
    Galletta A; Amato G
    Minerva Stomatol; 1998 Jun; 47(6):283-6. PubMed ID: 9738363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia.
    Lennox PA; Harries M; Lund VJ; Howard DJ
    J Laryngol Otol; 1997 Jan; 111(1):34-7. PubMed ID: 9292128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C
    Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Septal fascioplasty as the method of surgical treatment of nose bleeding in patients with Rendu-Osler-Weber disease].
    Lepkowski A; Pawełczyk M; Wróbel M; Markowski J
    Otolaryngol Pol; 1992; 46(6):565-72. PubMed ID: 1301549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reconstruction of the nasal septum combined with septal dermoplasty in Rendu-Osler-Weber's disease (author's transl)].
    Kastenbauer ER
    Laryngol Rhinol Otol (Stuttg); 1977 Nov; 56(11):890-4. PubMed ID: 145523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous embolization to control epistaxis in Rendu-Osler-Weber disease.
    Strother CM; Newton TH
    Arch Otolaryngol; 1976 Jan; 102(1):58-60. PubMed ID: 1244834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resurfacing the nasomaxillary cavity for management of epistaxis in Osler-Rendu-Weber disease.
    Bedongi A; McCombe D; Kennedy J; Morrison W
    J Plast Reconstr Aesthet Surg; 2006; 59(5):537-40; discussion 536. PubMed ID: 16749201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
    Harvey RJ; Kanagalingam J; Lund VJ
    Am J Rhinol; 2008; 22(2):182-7. PubMed ID: 18416977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary HaemorrhagicTelangiectasia--A Rare Cause of Severe Anaemia.
    Deshpande P; Bhat S; Karmarkar A
    J Assoc Physicians India; 2014 Dec; 62(12):48-51. PubMed ID: 26259423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nd:YAG laser treatment of recurrent epistaxis in heredity hemorrhagic telangiectasia.
    Velegrakis GA; Prokopakis EP; Papadakis CE; Helidonis ES
    J Otolaryngol; 1997 Dec; 26(6):384-6. PubMed ID: 9438937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.